HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Olesinska Selected Research

AB 74

7/2010Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Olesinska Research Topics

Disease

4Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2016 - 09/2010
3Rheumatoid Arthritis
02/2017 - 10/2014
2Autoimmune Diseases (Autoimmune Disease)
02/2017 - 10/2014
1Hypertension (High Blood Pressure)
02/2017
1Leukopenia
07/2010
1Arthritis (Polyarthritis)
07/2010
1malar rash
07/2010

Drug/Important Bio-Agent (IBA)

2CytokinesIBA
02/2017 - 10/2014
2Interleukin-27 (Interleukin 27)IBA
07/2016 - 10/2014
1Interleukin-12 (IL 12)IBA
02/2017
1Transcription Factors (Transcription Factor)IBA
03/2015
1Rituximab (Mabthera)FDA Link
01/2012
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2011
1AB 74IBA
07/2010

Therapy/Procedure

2Therapeutics
01/2012 - 09/2010